Novus Biologicals CD300c/LMIR2 Protein
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Manufacturer: Novus Biologicals NBP184432PEP
DescriptionA recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human CD300C. The CD300c/LMIR2 Recombinant Protein Antigen is derived from E. coli. The CD300c/LMIR2 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
This is a blocking peptide for NBP1-84432. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.
|PBS and 1M Urea, pH 7.4.|
|Store at -20°C. Avoid freeze-thaw cycles.|
Safety and Handling
ShelfLife : 365
For Research Use Only